Océanie · Marchés régionaux · Stockhead

Orthocell partner receives US FDA clearance for marine-derived bone graft

Publié par Stockhead · Australie il y a 1 h

Perth-based Orthocell has finalised a strategic investment in Marine Biomedical in January 2026, increasing its equity interest to 12% for ... Read More The post Orthocell partner…

Lire l'article complet sur Stockhead Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stockhead.com.au)

Orthocell partner receives US FDA clearance for marine-derived bone graft

À lire aussi

Uranium price tipped to rise 38%. Here's why and the ASX shares brokers rate a buy

Westbridge buys $43m QLD medical asset

You don't need to miss a payment to get help

North Korea denies role in Binance heist as customers withdraw billions

Carry It Like Makybe

IFM Investors appoints global product strategy head

Orthocell partner receives US FDA clearance for marine-derived bone graft

Partager

À lire aussi

Uranium price tipped to rise 38%. Here's why and the ASX shares brokers rate a buy

Westbridge buys $43m QLD medical asset

You don't need to miss a payment to get help

North Korea denies role in Binance heist as customers withdraw billions

Carry It Like Makybe

IFM Investors appoints global product strategy head